^a Tested in dextrose 5%.

^b Tested in sodium chloride 0.9%.

^c Refer to Appendix for the composition of parenteral nutrition solutions. TNA indicates a 3-in-1 admixture, and TPN indicates a 2-in-1 admixture.

^d Tested in dextrose 5% in sodium chloride 0.225%.

^e Tested in Ringer’s injection, lactated.

^f Tested in both dextrose 5% and sodium chloride 0.9%.

^g Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.

^h Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.

ⁱ Ceftazidime component. Ceftazidime in a 4:1 fixed-ratio concentration with avibactam.

^j Not specified whether concentration refers to potassium or phosphates content.

^k Concentration refers to potassium content.

^l Imipenem component. Imipenem in a 2:2:1 fixed-ratio concentration with cilastatin and relebactam.

^m Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.